Avoro Capital Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,200,000
| Closed | -$15.1M | – | 39 |
|
|
2024
Q4 | $15.1M | Buy |
+1,200,000
| New | +$15.1M | 0.21% | 37 |
|
|
2024
Q2 | – | Sell |
-1,260,900
| Closed | -$34M | – | 44 |
|
|
2024
Q1 | $34M | Hold |
1,260,900
| – | – | 0.4% | 39 |
|
|
2023
Q4 | $37.8M | Buy |
1,260,900
+10,900
| +0.9% | +$327K | 0.52% | 27 |
|
|
2023
Q3 | $25.6M | Buy |
+1,250,000
| New | +$25.6M | 0.4% | 28 |
|
|
2019
Q4 | – | Sell |
-285,714
| Closed | -$3.33M | – | 34 |
|
|
2019
Q3 | $3.33M | Hold |
285,714
| – | – | 0.14% | 33 |
|
|
2019
Q2 | $4.29M | Buy |
+285,714
| New | +$4.29M | 0.15% | 31 |
|